节点文献
ⅢA-N2期非小细胞肺癌术后应用以异环磷酰胺为主的联合化疗的远期疗效
LONG TERM RESULTS OF ADJUVANT CHEMOTHERAPY FOR POST-RESECTED NSCLC STAGE ⅢA-N2 WITH SPECIAL REFERENCE TO IFOSFAMIDE COMBINATION CONTINOUS INFUSION.
【摘要】 25例ⅢA—N2期非小细胞肺癌患者术后采用阿霉素（或表阿霉素）、异环磷酰胺、顺铂联合辅助化疗,预期5年生存率24～28％,认为辅助化疗有帮助,少数患者有明显白细胞减少,但均能恢复。
【Abstract】 Adjuvant chemotherapy of 25 cases of NSCLC stage IDA-N 2 with a c-ombination of doxorubicin (or Epirubicin) , Ifosfamide and cisplatin were reported. The expected 5 years survial was 24-28% for the guoup. No severe side effects except leucopenia were encountered.
- 【文献出处】 癌症 ,Chinese Journal of Cancer , 编辑部邮箱 ,1992年03期
- 【下载频次】17